These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


203 related items for PubMed ID: 3051339

  • 1. [Drug therapy in peripheral arterial occlusive disease].
    Bollinger A.
    Schweiz Med Wochenschr; 1988 Sep 10; 118(36):1283-9. PubMed ID: 3051339
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Prostanoids in therapy of peripheral arterial occlusive disease.
    Creutzig A, Caspary L.
    Therapie; 1991 Sep 10; 46(3):241-5. PubMed ID: 1792658
    [Abstract] [Full Text] [Related]

  • 5. [Improvement of walking disability and conservative treatment. Guiding principles for drug treatment of chronic arterial occlusive disease (stage I and IIb)].
    Heinrich F.
    Fortschr Med; 1984 Sep 27; 102(36):74-5. PubMed ID: 6489898
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Prostacyclin and pentoxifylline in the treatment of patients with inoperable occlusions of the peripheral arteries of the lower extremities].
    Maksimović ZV.
    Srp Arh Celok Lek; 1999 Sep 27; 127(7-8):249-53. PubMed ID: 10624398
    [Abstract] [Full Text] [Related]

  • 8. [Treatment strategies in arterial occlusive diseases].
    Bollinger A.
    Schweiz Rundsch Med Prax; 1993 Nov 23; 82(47):1354-8. PubMed ID: 8272701
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Peripheral arterial occlusive disease: conservative treatment of intermittent claudication.
    Kriessmann A.
    J Cardiovasc Pharmacol; 1990 Nov 23; 16 Suppl 3():S72-4. PubMed ID: 1369724
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Peripheral arterial disease: drug therapy.
    Schwartz JB.
    J Gend Specif Med; 2002 Nov 23; 5(4):16-20. PubMed ID: 12192882
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effects of defibrotide on physical performance and hemorheologic picture in patients with peripheral arteriopathy.
    Marrapodi E, Leanza D, Giordano S, Nazzari M, Corsi C.
    Clin Trials Metaanal; 1994 Apr 23; 29(1):21-30. PubMed ID: 10150182
    [Abstract] [Full Text] [Related]

  • 17. Pharmacologic therapy for peripheral arterial disease and claudication.
    Hiatt WR.
    J Vasc Surg; 2002 Dec 23; 36(6):1283-91. PubMed ID: 12469066
    [Abstract] [Full Text] [Related]

  • 18. [Value of vasoactive drugs in conservative therapy of peripheral arterial occlusive disease].
    Scheffler A, Rieger H.
    Z Arztl Fortbild Qualitatssich; 1999 Nov 23; 93(9):639-44. PubMed ID: 10666827
    [Abstract] [Full Text] [Related]

  • 19. [Preventive treatment of cerebrovascular accidents of arterial origin].
    Castillo V, Bogousslavsky J, Vuadens P.
    Praxis (Bern 1994); 1996 Feb 06; 85(6):159-63. PubMed ID: 8701178
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.